Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Docetaxel recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Docetaxel (8 total). Check the affected lots below.

Most common reason: Packaging defect (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Docetaxel. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Docetaxel recalls on record

none so far in 2026; 8 on record, newest first
Class I · High risk

Docetaxel Injection

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Ongoing Particulate / foreign matter Sagent Pharmaceuticals NDC 25021-254-08 D-0554-2024
Class I · High risk

Docetaxel Injection

Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Ongoing Particulate / foreign matter Sagent Pharmaceuticals NDC 25021-254-08 D-0553-2024
Class II · Moderate risk

Docetaxel Injection USP

Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.

Terminated Packaging defect Dr. Reddy's Laboratories, Inc. NDC 43598-259-40 D-1001-2019
Class II · Moderate risk

Docetaxel injection concentrate

Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.

Terminated Wrong potency / content Sanofi-Aventis U.S. LLC NDC 0955-1020-01 D-0804-2018
Class II · Moderate risk

Docetaxel Injection USP

Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.

Terminated Packaging defect Dr. Reddy's Laboratories, Inc. NDC 43598-611-11 D-0213-2018
Class II · Moderate risk

Docetaxel Anhydrous active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-636-2015